Mattern Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Mattern Wealth Management's BMY Position: Q2 2026 in Review
Mattern Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,800 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #171.
Mattern Wealth Management first reported a position in BMY in Q1 2020 and has held it in 24 quarters since. The position peaked at $424K in Q2 2022. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mattern Wealth Management held 3,800 shares of Bristol-Myers Squibb worth $219K as of Q2 2026.
- Mattern Wealth Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.04% of Mattern Wealth Management's portfolio in Q2 2026, its #171 holding.
- Mattern Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 24 quarters since.
- Mattern Wealth Management's Bristol-Myers Squibb position peaked at $424K in Q2 2022.
- 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mattern Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.